Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
20 drugs in development
By Therapeutic Area
top 6
R&D Momentum
79/100
Pipeline Velocity
50/100
Trial Completion Rate
64/100
Pipeline Concentration
13/100
Pipeline Freshness
63/100
Strategic Signals
Activity
Last 14 days
Effect of Glucagon-like Peptide -1 Receptor Agonist on Liver Tissue and Plasma Lipids in MASLD
Group Singing (Hybrid Format) or Solo Singing in Older Adults With Coronary Artery Disease: A Feasibility Study
Exogenous Tuning of Neural Oscillations as a Mode of Treatment in Post-stroke Aphasia
Probing Language Processes Using Transcranial Magnetic Stimulation
Phase I Study Evaluating Safety and Feasibility of Hematopoietic Stem Cell Gene Transfer That Targets Factor VIII Delivery From Platelets for Patients With Hemophilia A
Diagnosis of Fatty Liver With Outpatient Ultrasound
Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors
Delayed Primary Closure Using Negative Pressure Wound Therapy
Feasibility Study for Quantifying Fatty Liver Using Thermo-acoustic Imaging
TACS for the Recovery of Phonological STM After Stroke
Precision Neuromodulation in Post-Stroke Aphasia Using TMS
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)